Figures & data
Table 1 Age, gender, and duration of RD in groups I and II
Table 2 OCT findings in both groups
Table 3 Specific OCT findings in each group
Figure 1 No disruption in the EZ or the ELM.
![Figure 1 No disruption in the EZ or the ELM.](/cms/asset/f54902bc-9064-4f5b-9b2b-9540132f61e2/doph_a_181595_f0001_c.jpg)
Figure 2 Disruption of EZ with normal ELM.
![Figure 2 Disruption of EZ with normal ELM.](/cms/asset/3e36c036-7d1a-46c2-b17a-a3b526873b80/doph_a_181595_f0002_c.jpg)
Figure 3 Combined disruption of the EZ and ELM.
![Figure 3 Combined disruption of the EZ and ELM.](/cms/asset/872acfd2-d497-4648-8059-6cde77c03799/doph_a_181595_f0003_c.jpg)
Figure 4 Early ERM ≤3 months with CME.
![Figure 4 Early ERM ≤3 months with CME.](/cms/asset/97e0c72c-8cf4-4eb8-b5ca-4a22cc31f96f/doph_a_181595_f0004_c.jpg)
Figure 5 Late ERM >6 months with CME.
![Figure 5 Late ERM >6 months with CME.](/cms/asset/26920b6a-2057-4e8d-b00f-bc489014acdc/doph_a_181595_f0005_c.jpg)
Table 4 OCT parameters of cases with no ERM and with mild-to-moderate disruption
Table 5 OCT parameters of cases with no ERM and with severe disruption
Table 6 Comparison of macular thickness and ONLT between operated eyes with no ERM from groups I and II
Figure 6 Correlation between 6-month postoperative LogMAR BCVA and severity of disruption.
![Figure 6 Correlation between 6-month postoperative LogMAR BCVA and severity of disruption.](/cms/asset/bef01c83-2c31-4083-bc93-b910c4d81888/doph_a_181595_f0006_c.jpg)
Figure 7 Correlation between 6-month postoperative LogMAR BCVA and ONLT.
![Figure 7 Correlation between 6-month postoperative LogMAR BCVA and ONLT.](/cms/asset/977d74b1-2ec0-4d7d-81af-a869f987fb08/doph_a_181595_f0007_c.jpg)
Figure 8 Correlation between 6-month postoperative LogMAR BCVA and average macular thickness.
![Figure 8 Correlation between 6-month postoperative LogMAR BCVA and average macular thickness.](/cms/asset/c5f0ae2a-c752-4bbd-966d-c3a732ed7c3c/doph_a_181595_f0008_c.jpg)